medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2025, Number 2

<< Back Next >>

Acta Med 2025; 23 (2)

Incidence of blood of transfusion in patients undergoing total knee arthroplasty at the CMN 20 de Noviembre

Farfán GJI, Sierra PM, Nuñez RJ

Language: Spanish
References: 36
Page: 109-114
PDF size: 232.85 Kb.


ABSTRACT

Introduction: primary total knee arthroplasty (TKA) is a major procedure, the definitive treatment for gonarthrosis in its final stages. Among the most relevant risks are excessive bleeding, requiring the use of blood transfusion, generating associated morbidity, and an increase in the use of material and financial resources in health institutions. In the Orthopedics service of the CMN 20 de Noviembre, the actual incidence of this condition has not been evaluated. Objective: to describe the incidence of transfusion of blood products in post-TKA patients at the CMN 20 de Noviembre. Material and methods: the clinical records of patients undergoing TKA at the CMN November 20 from January 2021 to December 2022 were reviewed. Results: a mathematical calculation of the incidence of transfusion of blood products in the 45 patients included in this study was performed. Study with an incidence of 6.7% of post-TKA patients at the CMN ISSSTE 20 de Noviembre for the previously described period. Conclusions: in the United States, it is estimated that 600,000 TKAs are performed annually, of which 20-44% require blood transfusions. Compared to our incidence of 6.7% in our center, it represents a substantially lower transfusion rate.


REFERENCES

  1. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum. 1986; 29 (8): 1039-1049.

  2. Weiss E. Knee osteoarthritis, body mass index and pain: data from the osteoarthritis initiative. Rheumatol (Oxford). 2014; 53 (11): 2095-2099.

  3. Charles-Lozoya S, Treviño-Báez JD, Ramos-Rivera JA, Rangel-Flores JM, Tamez-Montes JC, Brizuela-Ventura JM. Metabolic syndrome and other factors associated to gonarthrosis. Gac Med Mex. 2017; 153 (7): 775-780.

  4. Prevención, Diagnóstico y Tratamiento de Rehabilitación en el Paciente Adulto con Osteoartrosis de Rodilla en los Tres Niveles de Atención. México: Instituto Mexicano del Seguro Social; 2014.

  5. Losina E, Walensky RP, Reichmann WM, Holt HL, Gerlovin H, Solomon DH et al. Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans. Ann Intern Med. 2011; 154 (4): 217-226.

  6. Nguyen USDT, Zhang Y, Zhu Y, Niu J, Zhang B, Felson DT. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: Survey and cohort data. Ann Intern Med. 2011; 155 (11): 725-732.

  7. Baker PN, Rushton S, Jameson SS, Reed M, Gregg P, Deehan DJ. Patient satisfaction with total knee replacement cannot be predicted from pre-operative variables alone: A cohort study from the national joint registry for England and Wales. Bone Joint J. 2013; 95-B (10): 1359-1365.

  8. Insall JN, Lachiewicz PF, Burstein AH. The posterior stabilized condylar prosthesis: a modification of the total condylar design. Two to four-year clinical experience. J Bone Joint Surg Am. 1982; 64 (9): 1317-23.

  9. Engh GA, Parks NL. Surgical technique of the midvastus arthrotomy. Clin Orthop Relat Res. 1998; 351: 270-274.

  10. Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PDJ. Infection rates after 3,175 total hip and total knee replacements performed with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg Am. 1982; 64 (4): 525-535. Available from: https://journals.lww.com/jbjsjournal/fulltext/1982/64040/infection_rates_after_3175_total_hip_and_total.7.aspx

  11. Spahn DR, Moch H, Hofmann A, Isbister JP. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology. 2008; 109 (6): 951-953.

  12. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004; 19 (3): 281-287.

  13. Kahlenberg CA, Nwachukwu BU, McLawhorn AS, Cross MB, Cornell CN, Padgett DE. Patient satisfaction after total knee replacement: a systematic review. HSS J. 2018; 14 (2): 192-201.

  14. Bisbe-Vives E, Moltó L. Therapeutic approach to postoperative anemia. Rev Esp Anestesiol Reanim. 2015; 62 (S1): 41-44. doi: 10.1016/S0034-9356(15)30006-2.

  15. Keating EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res. 1998; 357: 50-59. Available from: https://journals.lww.com/corr/fulltext/1998/12000/predictors_of_transfusion_risk_in_elective_knee.8.aspx

  16. Larocque BJ, Gilbert K, Brien WF. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion. 1997; 37 (5): 463-467.

  17. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: Analysis of predictive factors. J Bone Joint Surg. 2002; 84 (2): 14-16.

  18. Surgenor DM, Wallace EL, Churchill WH, Hao SHS, Chapman RH, Poss R. Red cell transfusions in total knee and total hip replacement surgery. Transfusion. 1991; 31 (6): 531-537.

  19. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty1. J Bone Joint Surg. 1999; 81 (1): 2-10. Available from: https://journals.lww.com/jbjsjournal/fulltext/1999/01000/an_analysis_of_blood_management_in_patients_having.2.aspx

  20. Vuille-Lessard É, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties. Transfusion. 2012; 52 (2): 261-270.

  21. Bezwada HP, Nazarian DG, Henry DH, Booth REJ. Preoperative use of recombinant human erythropoietin before total joint arthroplasty. J Bone Joint Surg. 2003; 85 (9): 1795-1800. Available from: https://journals.lww.com/jbjsjournal/fulltext/2003/09000/preoperative_use_of_recombinant_human.20.aspx

  22. Klika AK, Small TJ, Saleh A, Szubski CR, Chandran-Pillai ALP, Barsoum WK. Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: Nationwide inpatient sample 2000-2009. J Arthroplasty. 2014; 29 (11): 2070-2077. doi: 10.1016/j.arth.2014.06.018.

  23. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006; 355 (6): 549-559. doi: 10.1056/NEJMoa061894.

  24. Hart A, Abou Khalil J, Carli A, Huk O, Zukor D, Antoniou J. (2014). Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. JBJS, 96(23), 1945-1951.

  25. Lu Q, Peng H, Zhou GJ, Yin D. Perioperative blood management strategies for total knee arthroplasty. Orthop Surg. 2018; 10 (1): 8-16.

  26. Slover J, Lavery JA, Schwarzkopf R, Iorio R, Bosco J, Gold HT. Incidence and risk factors for blood transfusion in total joint arthroplasty: analysis of a statewide database. J Arthroplasty. 2017; 32 (9): 2684-2687.e1. doi: 10.1016/j.arth.2017.04.048

  27. Jeschke E, Citak M, Halder AM, Heller KD, Niethard FU, Schrader P et al. Blood transfusion and venous thromboembolism trends and risk factors in primary and aseptic revision total hip and knee arthroplasties: A nationwide investigation of 736,061 cases. Orthop Traumatol Surg Res. 2022; 108 (1): 102987.

  28. Abdullah HR, Ranjakunalan N, Yeo W, Tan MH, Poopalalingam R, Sim YE. (2019). Association between preoperative anaemia and blood transfusion with long-term functional and quality of life outcomes amongst patients undergoing primary total knee arthroplasty in Singapore: a single-centre retrospective study. Qual Life Res. 2019; 28 (1): 85-98.

  29. Dobarganes-Barlow FG, López-Villers A, Trueba-Vasavilbaso C, Navarrete-Álvarez JM, Rebuelta-Cancio AA, Guevara-Álvarez A et al. Use of tranexamic acid in primary total knee arthroplasty. Acta Ortop Mex. 2019; 33 (6): 352-356.

  30. Jennings JD, Solarz MK, Haydel C. Application of tranexamic acid in trauma and orthopedic surgery. Orthop Clin North Am. 2016; 47 (1): 137-143. doi: 10.1016/j.ocl.2015.08.014.

  31. Mufarrih SH, Qureshi NQ, Ali A, Malik AT, Naim H, Noordin S. Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population. BMC Musculoskelet Disord. 2017; 18 (1): 359.

  32. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43 (4): 459-469.

  33. Carling MS, Jeppsson A, Eriksson BI, Brisby H. (2015). Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015; 10: 48.

  34. Bedard NA, Elkins JM, Brown TS. Effect of COVID-19 on hip and knee arthroplasty surgical volume in the United States. J Arthroplasty. 2020; 35 (7S): S45-S48. doi: 10.1016/j.arth.2020.04.060.

  35. Barnes CL, Zhang X, Stronach BM, Haas DA. The initial impact of COVID-19 on total hip and knee arthroplasty. J Arthroplasty. 2021; 36 (7): S56-S61. doi: 10.1016/j.arth.2021.01.010.

  36. Themistoklis T, Theodosia V, Konstantinos K, Georgios DI. Perioperative blood management strategies for patients undergoing total knee replacement: where do we stand now? World J Orthop. 2017; 8 (6): 441-454.




2020     |     www.medigraphic.com